New indications for exenatide therapy of type 2 diabetes mellitus

New indications for exenatide therapy of type 2 diabetes mellitus

Obesity associated with the enhanced risk of cardiovascular disorders plays a key role in the evolvement and progression of type 2 diabetes mellitus(DM2). Incretin mimetics are the sole class of hypoglycemic agents that not only effectively correct hyperglycemia but also reduce body weight. Exenatid...

Full description

Bibliographic Details
Main Authors:	Olga Konstantinovna Vikulova, Marina Vladimirovna Shestakova
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2010-09-01
Series:	Сахарный диабет
Subjects:	type 2 diabetes mellitus obesity incretin mimetics exenatide byetta
Online Access:	https://www.dia-endojournals.ru/jour/article/view/5496

Similar Items

Exenatide Use in the Management of Type 2 Diabetes Mellitus
by: Angelos Kyriacou, et al.
Published: (2010-08-01)

Pharmalogical effects and results of clinical trials of the first incretinomimetic exenatide
by: Alexander Sergeevich Ametov, et al.
Published: (2011-09-01)

Glucagon-like peptide-1 analogues: An overview
by: Vishal Gupta
Published: (2013-01-01)

The Effect of GLP-1 Agonist Treatment On Subclinical Atherosclerosis
by: Davut Sakız, et al.
Published: (2022-07-01)

Exenatide improves hepatocyte insulin resistance induced by different regional adipose tissue
by: Chuanmin Bai, et al.
Published: (2022-09-01)

Critical appraisal of once-weekly formulation of exenatide in the control of type 2 diabetes mellitus
by: Seewoodhary J, et al.
Published: (2010-05-01)

Innovations in the treatment of type 2 diabetes mellitus: use of incretins
by: Ivan Ivanovich Dedov, et al.
Published: (2010-10-01)

CARDIOPRODUCTIVE EFFECTS OF EXXENATE AMID AND VILDAGLIPTIN INCRETIN MIMETICS IN DOXYRUBRICINE CARDIOMYOPATHY MODELING
by: A. P. TARASOVА, et al.
Published: (2017-09-01)

The effect of exenatide on fasting bile acids in newly diagnosed type 2 diabetes mellitus patients, a pilot study
by: Boyu Li, et al.
Published: (2020-06-01)

Pharmacokinetics and efficacy of PT302, a sustained-release Exenatide formulation, in a murine model of mild traumatic brain injury
by: Miaad Bader, et al.
Published: (2019-04-01)

Effects of PPARD gene variants on the therapeutic responses to exenatide in chinese patients with type 2 diabetes mellitus
by: Jinfang Song, et al.
Published: (2022-08-01)

Triple therapy for obese patients with type 2 diabetes: evaluating effectiveness of the metformin + exenatide + glibenclamide combination
by: M. B. Antsiferov, et al.
Published: (2015-12-01)

The first successful desensitization protocol in exenatide allergy: a case report
by: Osman Ozan Yeğit, et al.
Published: (2023-01-01)

Exenatide and Metformin Improve Serum Indices and Intestinal Flora in patients with Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease
by: Xiaojie Jiang, et al.
Published: (2023-12-01)

New prospects in the treatment of diabetes mellitus
by: Minara Shamkhalovna Shamkhalova, et al.
Published: (2012-12-01)

An experimental study of exenatide effects on renal injury in diabetic rats
by: Xiaodong Wang, et al.
Published: (2019-02-01)

The Changes of Lipidomic Profiles Reveal Therapeutic Effects of Exenatide in Patients With Type 2 Diabetes
by: Lin Zhang, et al.
Published: (2022-03-01)

Ion- and osmoregulating renal functions in patients with type 2 diabetes mellitus
by: Evgeniya Vladimirovna Balbotkina, et al.
Published: (2016-01-01)

Exenatide and Dapagliflozin Combination Enhances Sertoli Cell Secretion of Key Metabolites for Spermatogenesis
by: João C. Ribeiro, et al.
Published: (2022-05-01)

Real-world glycemic outcomes in patients with type 2 diabetes initiating exenatide once weekly and liraglutide once daily: a retrospective cohort study
by: Saunders WB, et al.
Published: (2016-07-01)

Effects of a 6-Month Exenatide Therapy on HbA1c and Weight in Korean Patients with Type 2 Diabetes: A Retrospective Cohort Study
by: Juyoung Shin, et al.
Published: (2012-10-01)

Safety, Tolerability, and Proof-Of-Concept Study of OKV-119, a Novel Exenatide Long-Term Drug Delivery System, in Healthy Cats
by: Michael Klotsman, et al.
Published: (2021-05-01)

Glibenclamide therapy: pros and cons
by: Olga Konstantinovna Vikulova, et al.
Published: (2011-09-01)

Angiotensin receptor blockers in nephroprotection at patients with diabetes mellitus: focus on losartan
by: Ol'ga Konstantinovna Vikulova, et al.
Published: (2009-09-01)

Exenatide for obesity in children and adolescents: Systematic review and meta-analysis
by: Bin Chen, et al.
Published: (2024-04-01)

Kontrol altında olmayan tip 2 diyabetes mellitus hastalarında insülin tedavisinden eksenatid bazlı tedaviye geçişin etkinliği
by: Cem Onur Kıraç, et al.
Published: (2020-09-01)

GLYCEMIC AND NON-GLYCEMIC EFFECTS OF EXENATIDE IN PATIENTS WITH DIABETES MELLITUS OF TYPE 2 (DM2) WITH MYOCARDIAL INFARCTION
by: A. Yu. BABENKO, et al.
Published: (2016-12-01)

BEYOND GLYCEMIC CONTROL IN DIABETES MELLITUS: EFFECTS OF INCRETIN-BASED THERAPY ON BONE METABOLISM
by: ELENA eCECCARELLI, et al.
Published: (2013-06-01)

Exenatide Improves Bone Quality in a Murine Model of Genetically Inherited Type 2 Diabetes Mellitus
by: Marie Pereira, et al.
Published: (2017-11-01)

Exaggerated liver injury induced by renal ischemia reperfusion in diabetes: Effect of exenatide
by: Vaghasiya Jitendra, et al.
Published: (2010-01-01)

Inсretin-based therapy in patients with type 2 diabetes and chronic kidney disease
by: Minara Shamkhalovna Shamkhalova, et al.
Published: (2012-09-01)

Association between exenatide use and incidence of Alzheimer's disease
by: Bo Zhou, et al.
Published: (2021-01-01)

Lipid metabolism and production of incretins in patients with obesity and type 2 diabetes mellitus after biliopancreatic diversion in Hess-Marceau modification at the early stages of follow-up
by: Ekaterina Ershova, et al.
Published: (2016-11-01)

National register of diabetes mellitus in Russian Federation.
by: Ivan Ivanovich Dedov, et al.
Published: (2015-10-01)

Effects of exenatide on cardiac function, perfusion, and energetics in type 2 diabetic patients with cardiomyopathy: a randomized controlled trial against insulin glargine
by: Weena J. Y. Chen, et al.
Published: (2017-05-01)

Effect of probiotics and incretine mimeticss on the levels of glucagon-like peptide-1 in blood serum of patients with type 2 diabetes mellitus
by: K.A. Shyshkan-Shyshova, et al.
Published: (2021-12-01)

Exenatide Once Weekly for Management of Type 2 Diabetes: A Review
by: Inaishi J, et al.
Published: (2022-02-01)

Two-Layer Sustained-Release Microneedles Encapsulating Exenatide for Type 2 Diabetes Treatment
by: Han Liu, et al.
Published: (2022-06-01)

Effects of exenatide versus insulin glargine on body composition in overweight and obese T2DM patients: a randomized controlled trial
by: Ting-Ting Yin, et al.
Published: (2018-10-01)

Clinical experience with exenatide in obese North Indian patients with type 2 diabetes mellitus
by: Tarunika Bawa, et al.
Published: (2013-01-01)